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Abstract
A method of intracranial transplantation of the tumor induced by adenovirus type 12 in syrian
hamster has been described. The incidence of intracranial tumor development was 86 (90.5 %) out
of 95 animals and the average survival time and tumor size at death were 15.1 days and 4.1 mm
in diameter respectively. The consistency of the days of death after intracranial transplantation of
the tumor was remarkable. The transplanted tumors developed preferentially at the site of implan-
tation and tumor cell seeding and tumor growing took place rarely along the ventricular system.
Glial or lymphoid cell response to the tumor was not observed at any stage after transplantation
in surrounding cerebral tissues of the animals. Histomorphologically, no elementary differences
were observed between intracranially transplanted tumors and serially transplanted subcutaneous
tumors. These facts permit the system to be applied to an experimental brain tumor model as
large-scale testing.
∗PMID: 4264054 [PubMed - indexed for MEDLINE] Copyright c©OKAYAMA UNIVERSITY
MEDICAL SCHOOL
Acta Med. Okayama 25, 605-613 (1971)
INTRACRANIAL TRANSPLANTATION OF THE TUMOR
INDUCED BY ADENOVIRUS TYPE 12 IN SYRIAN HAMSTER
- AN EXPERIMENTAL BRAIN TUMOR MODEL --
Kazuo T ABUCHI
Department oj Neurological Surgery, Okayama University Medical School, Okayama, Japan
(Director: Prof. Akira Nishimoto)
Received jor publication, Oct. 1, 1971
Many agents, including oncogenic viruses, chemical carcinogens
and irradiation are being used to induce an experimental brain tumor in
laboratory animals 0-18) and also intracranial transplantation of various
tumors induced by chemical carcinogens is attempted by many investiga-
tors (5, 19-22). There is, however, no attempt made on intracranial
transplantation of tumors induced by oncogenic viruses. Since the report
by TRENTIN et at. (23) on adenovirus type 12 which induces tumor in
newborn hamsters, several opinions of its cellular origin have been advo-
cated (23-28), and OGAWA et at. suggested (29-31) that the tumor is of
undifferentiated neuroectodermal origin.
The present roport deals with our method of making an experimental
brain tumor model in syrian hamsters by intracranial transplantation of
the tumor induced by adenovirus type 12.
MATERIALS AND METHODS
Animals: Syrian golden hamsters (Mesocricetus auratUJ) commercially available
in Japan were used. The animals used for the virus inoculation were less than 24
hours old.
Virus: Adenovirus type 12, prototype strain Huie, was obtained by the cour-
tesy of Dr Y. YABE from the Cancer Institute of Okayama University Medical
School.
Tumor: Adenovirus type 12-induced tumors were obtained by subcutaneous
inoculation of newborn hamsters with O. 1 ml of adenovirus type 12 of
102 5TCID50/O.1 ml. Typical adenovirus type 12-induced tumors appeared 6 to 8
weeks after virus inoculation as reported by many investigators (25, 27, 30).
Transplantation: The necrotic material and connective tissue capsule were
removed from the tumor, and the remainder of the tumor tissue was cut into 1
cu mm pieces in phosphate buffered saline (pH 7.2). Each piece was then placed
in a trocar lumen with the tip of No. 21 by sucking the tumor fragment, then
the trocar with a piece of tumor ready for implantation was inserted into the
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hamster's cerebral cortex by removing a 2x 2 mm piece of calvarium and dura
over the left frontoparietal region of hamsters five to six-week old, weighing 60
to 70 g under Nembutal anesthesia, and intracranial implantation was accom-
plished aseptically by pushing the trocar content with the stylet.
In a similar manner, a tumor fragment was placed in the subcutaneous tissue
of the flank of young adult hamsters for tumor maintenance, but in this instance,
a No. 13 trocar containing tumor fragment was used for implantation.
The tumor so induced was transplanted successively over 30 generations and
the samples of each tumor were fixed and stained with Hematoxylin and Eosin
(H. E.) at regular intervals, and were examined for histological stability. In a
series of the experiments, some animals were also sacrificed every other day after
transplantation to observe the course of tumor growth and development in the
intracerebral site.
Preparation of tissue sections: The hamster brains with tumor were fixed in 10%
neutral formalin and embedded in paraffin, and with some of them, serial sec-
tions of the whole brain were prepared mostly on the frontal plane. The sections
were stained with H. E. and some of sections with phosphotungstic acid-hemato-
xylin (PTAH).
RESULTS
Clinical course of the tumor bearing animals: After tumor implantation
the animals recovered from the anesthesia and resumed their routine
activity in the cage within 6 hours. No pathological signs following tumor
implantation were seen until approximately 5 days prior to death. The
animals which devoloped intracrainal tumor at first showed general
malaise and remarkable ventriflexion with gradual loss of weight, and
finally they became languid and cachexic. All of these signs were not
necessarily present prior to death.
Distribution, growth and spread of tumor: The growth of intracranially
transplanted tumor was followed serially. Early in the course of the
transplantation, the tumor cells proliferated at the site of implantation
and eventually occupied most of the left cerebral hemisphere of the animal
brain (Fig. 1). The tumor mass occasionally grew out through the cranial
defect as a narrow stalk of cells which then produced a dome.shaped su b.
cutaneous tumor nodule. Tumor cell seeding and tumor growth take
Fig. 1. Whole section of hamster brain bearing growing transplant of adenovirus type
12-induceed tumor H. E., X 5.5
Fig. 2. The tumor is clearly demarcated from the surrounding cerebral tissue in which
the edematous change can be orbserved H. E., X 100
Fig. 3. Invasion of tumor cells into the cerebral tissue H. E., X 40
Fig. 4. Characterisitc cell arrangement of the adenovrus type 12-induced tumor H. E.,
X 400
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place rarely along the ventricular system in the brain. None of the tumors
made extracranial metastasis as observed macroscopically by autopsies.
No increase in the size of the skull was seen in animals in spite of the
rapid growth of tumor. Usually, the growth of the tumor was expansive
and the tumor was demarcated clearly from the surrounding cerebral
tissues in which the edematous changes could be observed (Fig. 2), but
partial invasion of tumor cells into the cerebral tissue was observed (Fig.
3). Neither glial nor lymphoid cell responses to the tumor were observed
in the surrounding cerebral tissue at any stage after the tumor implanta.
tion.
Histomorphological observation: Histomorphologically, the serially
transplanted subcutaneous tumors were almost the same, and also no
difference was observed between intracranially transplanted tumors and
serially transplanted subcutaneous tumors. The cell arrangement was
mostly irregular, but some parts of the tumor showed the identical
characteristic cell arrangement of the tumor induced by adenovirus type
12 as described precisely by OGAWA, et al. (3 n As shown in Fig. 4, small
spindle shaped cells were attached to the stroma with fine protoplasmic
process and in some areas they showed palisade arrangement, pseudoro.
sette or small rosette-like structure. Furthermore, anaplastic bizarre giant
cells often appeared. Some mitotic figures were also observable in the
tumor and occasionally the tumor tissue showed some tiny necrotic areas
according to the stage of the tumor growth.
Incidence of tumor development: The incidence of tumor development
in animals of intracranial implantation was 86 (90.5 %) out of 95 animals.
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Fig. 5. The correlation between the size of tumor and the survival time of
each animal at death
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Only 9 (9.5 %) out of the 95 animals survived longer than 60 days after
the transplantation, which were considered to be of failure of tumor
development and no tumor was found in the brain of 4 animals of those
sacrificed on the 65th day after implantation.
Correlation between the size of the tumor and the survival time of the animals:
The growth of the intracranially transplanted tumor was rapid, and the
tumor bearing animals rarely survived more than 3 weeks after transplan.
tation. The average survival time was 15. 1 days after transplantation. In
these animals, the size of tumors at death ranged from 3-6 mm (average
4. 1 mm in diameter). Fig. 5 shows the correlation between the size of
tumor and the survival time of each animal at death.
DISCUSSION
For making experimental brain tumors, many chemical carcinogens
and viruses are applied to the laboratory animals (3), and also the suc-
cessful transplantation of chemically induced tumors to the brain of labo-
ratory animals has been reported (5, 19-22). Transplantation of human
brain tumors to the brain of laboratory animals was also attempted by
many investigators (32-34).
However, there has been no experimental report about the intrac-
ranial transplantation of virus.induced tumors to the brain of laboratory
animals except for one report by BERMAN which was not a histomorpholo-
gical but an immunological study (35). In the present investigation for
intracranial transplantation of the adenovirus type l2.induced tumor, it
was of interest to know that the tumor mass developed preferentially at
the site of implantation in the brain of animals, and the growth was
expansive.
On the other hand, it was reported by OGAWA et al. (29) that the
tumors induced by adenovirus type 12 in the central nervous system of
newborn hamsters (incidence being 37.2 %) were observed to develop in
various places of the brain, such as in the subependymal region of
ventricles of the brain and central canal of the spinal cord, and in the
meninges. These facts show that the site of tumor development is more
localized and consistent with the site of implantation in the transplanted
tumors. The use of the intracranially transplanted tumor induced by
adenovirus type 12 as an experimental brain tumor model is subject to
some criticism. First, the tumor genesis is controversial among many
investigators (24-27), but many endeavors were done by OGAWA et al.
(29-31) to search the origin of the tumor cells induced by adenovirus type
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12, and they suggested that histologically, the tumor possessed the
characteristics of undifferentiated neuroectodermal tumors. Histomor-
phologically, there are no essential differences between intracranially
and subcutaneously induced tumors. The multifarious appearance of
histological pattern which seems to be a marked characteristic of this
tumor, may be due to not only immature tumor, but also mixed compo-
sition of several groups of different cell types and, furthermore, of many
bizarre giant cells. Purification of tumor cells was not observed by intra-
cranial transplantations or by serial subcutaneous passages. Secondly, the
implantation procedure may be not precise enough and non-quantitative.
To be exact, the angles of needle placement of tumor implantation may
not be constant from animal to animal. The site of development of trans-
planted tumor in the animal brain is, however, localized and consistent
with the site of implantation and more than 90 % of the inoculated ani-
mals died within a consistent time range. From these facts, the system of
transplantation can be applied to an experimental brain tumor model as
large-scale testing.
As pointed out by GREENE (36), one of the major disadvantages of
employing the brain as a site for tumor implantation is the inability of the
investigator to see or to palpate the growing transplanted tumor. Neurolo-
gical signs suggestive of intracranial growth do not become apparent until
shortly before death, and there is nothing in the animal behavior to indi-
cate the presence or absence of tumor growth. It was described by SMITH
et at. (37) that tumor isografts to mouse brain elicited a small cell infiltra-
tion which dissipated by 16 days, leaving a flourishing tumor, and migra-
tion of large mononuclear cells from the blood stream into cerebral tissue
surrounding the tumor was observed. Some of these cells were monocytes,
many of them were apparently mediumJarge lymphocytes. From a more
particular point of view, it was interesting in the author's study that
neither glial nor lymphoid cell response to the transplants was observed
in surrounding cerebral tissue, and this fact may be explained by immu-
nological properties of the tumor or the brain (35, 38). There was no
evidence of inflammatory reaction in adjacent cerebral tissues, and the
tumor was abundantly supplied with thin. walled blood vessels. Approxi-
mately, the incidence of tumor take in the cerebral tissue was the same
as that obtained in the subcutaneous transplantation of the tumor (39). As
the tumors grow to larger size, they are always medullary with minimum
of connective tissue stroma, representing similar findings to those in
almost pure culture, and offer an unique material for model of experimen-
tal brain tumor.
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There are two possibilities concerned with failure of tumor takes, one
may be due to tumor -host relationship of individual animals, and the
other, due to lack of enough tumor cells to grow in the transplanted site.
Although the tumors were histologically the same, they may differ in
their growth characteristics. In the individual animals, the range of
days of death may be explained by the variability in the transplantation
technique, by the quantity of tumor implanted, by the precise location
of the tumor, and by the external decompression through the trephine
hole. Also, the neurological deficits produced and the coincident altera-
tion in the functional state of the animals, such as feeding, drinking,
and ambulating activities, may influence the time of death. In spite of
these variables, the consistency of the days of death after transplantation
was remarkable.
CONCLUSION
A method of intracranial transplantation of the tumor induced by
adenovirus type 12 in syrian hamster has been described. The incidence
of intracranial tumor development was 86 (90.5 %) out of 95 animals and
the average survival time and tumor size at death were 15.1 days and 4.1
mm in diameter respectively. The consistency of the days of death after
intracranial transplantation of the tumor was remarkable. The transplan-
ted tumors developed preferentially at the site of implantation and tumor
cell seeding and tumor growing took place rarely along the ventricular
system. Glial or lymphoid cell response to the tumor was not observed
at any stage after transplantation in surrounding cerebral tissues of the
animals.
Histomorphologically, no elementary differences were observed be-
tween intracranially transplanted tumors and serially transplanted subcu-
taneous tumors.
These facts permit the system to be applied to an experimental brain
tumor model as large-scale testing.
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